Last year, the president signed the Medicare Access & CHIP Reauthorization Act of 2015 (MACRA), which creates a new payment model for seasoned Medicare providers. Final rules are expected on November 1.
September 13, 2016 | Julie Miller, Editor in Chief
Commercial health insurers paid treatment centers and other providers $445.7 million to treat plan members’ opioid dependence and abuse in 2015, demonstrating a 1,375% spending increase over five years.
As part of a $300 million settlement, UnitedHealthcare will no longer require policyholders to demonstrate abstinence from drugs and alcohol for six months before receiving coverage for a costly hepatitis C medication.
The number of new coalitions and collaborations that have popped up just in the past year or so is a sure sign of everyone’s passion to make changes in how addiction treatment is delivered and how it is reimbursed.